BENGALURU (Reuters) – Dabur India said on Wednesday a U.S. court has dismissed two of its three units as defendants in a lawsuit that alleged use of products that caused ovarian cancer, uterine cancer and other health issues.
(Reporting by Hritam Mukherjee in Bengaluru; Editing by Arun Koyyur)
